Replimune (REPL)

44.33 -0.11 (0.25%)

Chart
Today 6M 1Y 5Y

Latest Headlines

Form 4 Replimune Group, Inc. For: Jan 14 Filed by: Astley-Sparke Philip January 19, 2021 9:54 PM - SEC Filing Form 4 Replimune Group, Inc. For: Jan 14 Filed by: Esposito Pamela January 19, 2021 9:51 PM - SEC Filing Form 4 Replimune Group, Inc. For: Jan 15 Filed by: Love Colin January 19, 2021 9:47 PM - SEC Filing Form 4 Replimune Group, Inc. For: Jan 14 Filed by: Omega Fund IV G.P. Manager, Ltd. January 19, 2021 3:03 PM - SEC Filing Form 4 Replimune Group, Inc. For: Jan 13 Filed by: Franchi Jean M. January 15, 2021 9:02 PM - SEC Filing Form 8-K Replimune Group, Inc. For: Jan 11 January 11, 2021 7:49 AM - SEC Filing Replimune (REPL) Provides 2020 Year End Review and Overview of Expected 2021 Milestones January 11, 2021 7:11 AM - StreetInsider Replimune Provides 2020 Year End Review and Overview of Expected 2021 Milestones January 11, 2021 7:00 AM - Globe NewsWire Replimune to Present at the 39th Annual J.P. Morgan Healthcare Conference January 6, 2021 8:00 AM - Globe NewsWire Replimune (REPL) Reports First Patient Dosed with RP3 in Phase 1 Clinical Trial in Patients with Advanced Solid Tumors January 5, 2021 8:02 AM - StreetInsider Replimune Announces First Patient Dosed with RP3 in a Phase 1 Clinical Trial in Patients with Advanced Solid Tumors January 5, 2021 8:00 AM - Globe NewsWire Form 4 Replimune Group, Inc. For: Dec 22 Filed by: Coffin Robert December 28, 2020 9:04 PM - SEC Filing Form 4 Replimune Group, Inc. For: Dec 23 Filed by: Esposito Pamela December 28, 2020 9:01 PM - SEC Filing Form 4 Replimune Group, Inc. For: Dec 18 Filed by: Rhodes Jason P December 22, 2020 4:39 PM - SEC Filing Form 8-K Replimune Group, Inc. For: Dec 15 December 21, 2020 9:20 AM - SEC Filing Form 4 Replimune Group, Inc. For: Dec 15 Filed by: Rhodes Jason P December 17, 2020 6:22 PM - SEC Filing Form 4 Replimune Group, Inc. For: Dec 14 Filed by: Franchi Jean M. December 16, 2020 9:01 PM - SEC Filing Form 4 Replimune Group, Inc. For: Dec 11 Filed by: Esposito Pamela December 15, 2020 9:36 PM - SEC Filing Form 4 Replimune Group, Inc. For: Dec 10 Filed by: Rhodes Jason P December 14, 2020 7:20 PM - SEC Filing Form 4 Replimune Group, Inc. For: Dec 09 Filed by: Astley-Sparke Philip December 11, 2020 9:01 PM - SEC Filing Form 4 Replimune Group, Inc. For: Dec 09 Filed by: Love Colin December 11, 2020 9:00 PM - SEC Filing Form 4 Replimune Group, Inc. For: Dec 07 Filed by: Rhodes Jason P December 9, 2020 7:55 PM - SEC Filing Form 4 Replimune Group, Inc. For: Dec 08 Filed by: SLATTERY JOSEPH P December 9, 2020 7:51 PM - SEC Filing Form 4 Replimune Group, Inc. For: Dec 07 Filed by: Dhingra Kapil December 9, 2020 7:48 PM - SEC Filing ZielBio Appoints Dieter Weinand Executive Chair as Company Heads Toward the Clinic with Lead Oncology Therapeutic December 9, 2020 7:06 AM - BizWire Form 4 Replimune Group, Inc. For: Nov 16 Filed by: Love Colin November 18, 2020 8:01 PM - SEC Filing BTIG Starts Replimune Group (REPL) at Buy November 17, 2020 5:44 AM - StreetInsider Replimune to Participate at the SVB Leerink Oncology 1x1 Day November 12, 2020 8:00 AM - Globe NewsWire KeyBanc Starts Replimune Group (REPL) at Overweight November 9, 2020 4:14 PM - StreetInsider Replimune Announces Poster Presentations at the SITC 2020 Annual Meeting and a Presentation at the SITC 2020 Annual Meeting Virtual Press Conference November 9, 2020 8:00 AM - Globe NewsWire Replimune Group (REPL) PT Raised to $57 at BMO Capital November 5, 2020 1:43 PM - StreetInsider Form 424B5 Replimune Group, Inc. November 5, 2020 9:01 AM - SEC Filing Form 8-K Replimune Group, Inc. For: Nov 05 November 5, 2020 8:20 AM - SEC Filing Form 10-Q Replimune Group, Inc. For: Sep 30 November 5, 2020 8:19 AM - SEC Filing Replimune Reports Fiscal Second Quarter Financial Results and Provides Corporate Update November 5, 2020 8:00 AM - Globe NewsWire Form 4 Replimune Group, Inc. For: Nov 02 Filed by: Lewis Tanya November 3, 2020 4:08 PM - SEC Filing Form 3 Replimune Group, Inc. For: Nov 02 Filed by: Lewis Tanya November 3, 2020 4:06 PM - SEC Filing UPDATE: Jefferies Starts Replimune Group (REPL) at Buy November 2, 2020 3:25 AM - StreetInsider Full Article List